Factor VIII gene therapy (GenStar/Baxter)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameFactor VIII gene therapy (GenStar/Baxter)
Drug Alias NameFactor VIII gene therapy (Corautus/Baxter)MaxAdFVIIIMAX-AD Factor VIII
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adenoviral vector
Mechanisms of ActionCoagulation factor VIII stimulantsBlood coagulation stimulants
TargetsCoagulation factor VIII
Therapy Area/IndicationsHemophilia A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesVia Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVia Pharmaceuticals
Active IndicationsN/A
Inactive IndicationsHemophilia A

Other Information

ATC CodeN/A
Related LinksN/A